Product
LOXO-783
Aliases
LY3849524
4 clinical trials
2 indications
Indication
Breast CancerIndication
HealthyClinical trial
A Study of LOXO-783 Administered as Monotherapy and in Combination With Anticancer Therapies for Patients With Advanced Breast Cancer and Other Solid Tumors With a PIK3CA H1047R MutationStatus: Recruiting, Estimated PCD: 2025-05-01
Clinical trial
A Phase 1, Open-label Two-part Study of the Absorption, Metabolism, Excretion, and the Absolute Bioavailability of [14C]-LOXO-783 in Healthy Adult SubjectsStatus: Not yet recruiting, Estimated PCD: 2024-01-11
Clinical trial
A Phase 1 Study to Evaluate the Effect of Food on the Pharmacokinetics of LOXO-783 in Healthy Adult SubjectsStatus: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
A Phase 1 Study to Investigate the Effect of Cholestyramine on the Pharmacokinetics of LOXO-783 in Healthy AdultsStatus: Completed, Estimated PCD: 2023-07-09